Synapse - Breast Medicine Service

Search Within

Breast Medicine Service

Results (4181)

Prognostic value of quantitative fluorodeoxyglucose measurements in newly diagnosed metastatic breast cancer

Journal Article

Ulaner, G. A.; Eaton, A.; Morris, P. G.; Lilienstein, J.; Jhaveri, K.; Patil, S.; Fazio, M.; Larson, S.; Hudis, C. A.; Jochelson, M. S.
Cancer Medicine (2013)

Fulltext@MSK | Save

The joys and challenges of caring for patients

Journal Article

Gilewski, T.
American Society of Clinical Oncology Educational Book (2013)

Fulltext@MSK | Save

Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to cisplatin and poly (ADP-ribose) polymerase inhibition

Meeting Abstract

Cavallo, F.; Graziani, G.; Antinozzi, C.; Feldman, D. R.; Houldsworth, J.; Bosl, G. J.; Chaganti, R. S. K.; Moynahan, M. E.; Jasin, M.; Barchi, M.
Cancer Research (2013)

Fulltext@MSK | Save

A phase II study of adjuvant paclitaxel (T) and trastuzumab (H) (APT trial) for node-negative, HER2-positive breast cancer (BC)

Meeting Abstract

Tolaney, S. M.; Barry, W. T.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; Ellis, M.; Shapira, I.; more...
Cancer Research (2013)

Fulltext@MSK | Save

High-depth massively parallel sequencing reveals heterogeneity between primary tumor and metastatic deposits in de novo metastatic breast cancer patients prior to exposure to systemic therapy

Meeting Abstract

Bidard, F. C.; Ng, C. K.; Piscuoglio, S.; Pierga, J. Y.; Cottu, P.; Norton, L.; Weigelt, B.; Sigal, B.; Reis-Filho, J. S.
Cancer Research (2013)

Fulltext@MSK | Save

Impact of the addition of carboplatin (Cb) and/or bevacizumab (B) to neoadjuvant weekly paclitaxel (P) followed by dose-dense AC on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)

Meeting Abstract

Sikov, W. M.; Berry, D. A.; Perou, C. M.; Singh, B.; Cirrincione, C.; Tolaney, S.; Kuzma, C. S.; Pluard, T. J.; Somlo, G.; Port, E.; more...
Cancer Research (2013)

Fulltext@MSK | Save

Patient characteristics and outcomes for patients with HER2-overexpressing breast cancer with brain metastases undergoing radiation therapy in the pre- and post adjuvant trastuzumab era

Meeting Abstract

Morikawa, A.; Diab, A.; Patil, S.; Yang, T. J.; Hudis, C. A.; McArthur, H. L.; Beal, K.; Seidman, A. D.
Cancer Research (2013)

Fulltext@MSK | Save

Acquired resistance to rapamycin and mTOR kinase inhibitors is mediated by non-overlapping mutations in distinct sites in the mTOR protein

Meeting Abstract

Rodrik-Outmezguine, V.; Yao, Z.; Berger, M.; De Stanchina, E.; Klinowska, T.; Barratt, D.; Baselga, J.; Rosen, N.
Cancer Research (2013)

Fulltext@MSK | Save

A phase 1 open-label, dose-escalation study evaluating the safety, tolerability, and pharmacokinetics of enzalutamide (previously MDV3100) alone or in combination with an aromatase inhibitor in women with advanced breast cancer

Meeting Abstract

Traina, T. A.; Yardley, D. A.; Patel, M.; Schwartzberg, L.; Elias, A.; Gucalp, A.; Peterson, A. C.; Hannah, A.; Gibbons, J.; Khondker, Z.; more...
Cancer Research (2013)

Fulltext@MSK | Save

Results from a phase 2a study of trastuzumab emtansine, paclitaxel, and pertuzumab in patients with HER2-positive metastatic breast cancer

Meeting Abstract

Elias, A.; Modi, S.; Krop, I. E.; Pegram, M.; Ipe, D.; Guardino, E. A.; Althaus, B.; LoRusso, P. L.
Cancer Research (2013)

Fulltext@MSK | Save